Despite a pause in U.S. tariffs, there is looming uncertainty and concern about how a potential trade war could hit Canada’s medicine supplies.
Canada has been given a 30-day reprieve from U.S. tariffs threatened by President Donald Trump, but that has done little to allay fears in the pharmaceutical realm.
“I think there’s a concern here that any sort of tariff war on this space could send ripples throughout the supply chain,” said Mina Tadrous, an assistant professor at the University of Toronto’s Leslie Dan Faculty of Pharmacy.
Tadrous told Global News the concern stems from the fact that the supply chain for medications is so global that the production of each drug crosses multiple borders before Canadians get the finished product from their local pharmacy.
“So, the structure of how tariffs work can have [an] add-on effect to how the drug pricing works,” he said.
More News
Image
PharmD for Pharmacists grad gains key clinical skills to expand career
Albert Villaluna complemented industry experience with clinical experiential courses that showed breadth of pharmacy practice in Canada.
Read More
Image
Next in Rx: What’s next for our PharmD grads
Natalie Chaput, Adam Da Costa Gomes, and Yas Zareyan reflect on a their final year in the PharmD program, shaped by hands-on learning and student leadership, experiences that offered lasting insight and impact.
Read More
Image
PharmD grad Kiera Miller set to practice in rural hospital
Experiential courses demonstrated the important role pharmacists play in providing health care in rural communities.
Read More